Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02735551Phase 4Terminated
Phase 4, randomised, open-label trial in unintended pregnancy (3 arms), sponsored by Oregon Health & Science University. Primary endpoint: Number of Participants Reporting Ongoing Use and Satisfaction at 3 months. Started Apr 2016; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02735551.